Prolactin Releasing Peptide (1-31), human, is a high-affinity GPR10 ligand that induces prolactin release. Human and rat Prolactin Releasing Peptide (1-31) bind to GPR10 with K_i values of 1.03 nM and 0.33 nM, respectively.
Lisuride maleate is an agonist of Dopamine receptor and anti-Parkinson's agent. Displays high affinity for D2, D3 and D4 receptors along with 5-HT1A. Exhibits some 5-HT2B receptor antagonist properties. Decreases prolactin release; reduces inflammatory me
FW 34569 is an enkephalin analogue. It stimulated growth hormones and prolactin release and inhibited the release of cortisol and LH, while FSH remained unchanged.
Lisuride is an orally active agonist of dopamine D2 receptors, classified as an ergot derivative. It is utilized for research purposes relating to Parkinson's disease, migraine, and elevated prolactin levels [1] [2].
Cabergoline diphosphate is a dopamine D2 receptor agonist used for prolactinoma treatment. Cabergoline permits rapid and effective hormonal and tumor control by normalizing prolactin-producing pituitary adenomas levels.
RFRP-1(human) TFA, an endogenous NPFF receptor agonist, exhibits potent activity with EC50 values of 0.0011 nM for NPFF2 and 29 nM for NPFF1. It significantly diminishes the contractile function of isolated rat and rabbit cardiac myocytes. Moreover, it decreases heart rate, stroke volume, ejection fraction, and cardiac output, while elevating plasma prolactin levels in rats.